Natrapharm
Zuellig
Otsuka (Philippines)

PATHEON INC

Featured products of Patheon
ponatinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
valganciclovir hydrochloride
Packing/Price
60's
MIMS Class
Antivirals
ATC Classification
J05AB14 - valganciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
metformin hydrochloride, sitagliptin
Packing/Price
28's (P621.60/box)
MIMS Class
Antidiabetic Agents
ATC Classification
A10BD07 - metformin and sitagliptin : Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
metformin hydrochloride, sitagliptin
Packing/Price
28's (P618.00/box)
MIMS Class
Antidiabetic Agents
ATC Classification
A10BD07 - metformin and sitagliptin : Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
Distributed by Natrapharm
metformin hydrochloride, sitagliptin
Packing/Price
28's (P621.60/box)
MIMS Class
Antidiabetic Agents
ATC Classification
A10BD07 - metformin and sitagliptin : Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
metformin hydrochloride, sitagliptin
Packing/Price
28's (P618.00/box)
MIMS Class
Antidiabetic Agents
ATC Classification
A10BD07 - metformin and sitagliptin : Belongs to the class of combinations of oral blood glucose lowering drugs. Used in the treatment of diabetes.
Distributed by Zuellig
ponatinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.
valganciclovir hydrochloride
Packing/Price
60's
MIMS Class
Antivirals
ATC Classification
J05AB14 - valganciclovir : Belongs to the class of nucleosides and nucleotides excluding reverse transcriptase inhibitors. Used in the systemic treatment of viral infections.
ponatinib
Packing/Price
30's
MIMS Class
Targeted Cancer Therapy
ATC Classification
L01EA05 - ponatinib : Belongs to the class of BCR-ABL tyrosine kinase inhibitors. Used in the treatment of cancer.

Sign up for Free to continue reading
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in